EXPRS2 closed today higher at kr1.46, an increase of 2.4561% from yesterday's close, completing a monthly decrease of -29.8077% or -kr0.62. Over the past 12 months, EXPRS2 stock lost -90.8291%.
EXPRS2 is not paying dividends to its shareholders.
The last earnings report, released on May 19, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -2.2365%, based on the last three reports.
ExpreS2ion Biotech Holding AB has completed 1 stock splits, with the recent split occurring on Oct 30, 2024.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XSTO (SEK).